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Abstract
Background: The effectiveness of provider-initiated HIV testing and counseling (PITC) for patients with sexually
transmitted infection (STI) in resource-constrained settings are of particular concern for high HIV prevalence
countries like South Africa. This study evaluated whether the PITC approach increased HIV testing amongst patients
with a new episode of sexually transmitted infection, as compared to standard voluntary counseling and testing
(VCT) at the primary care level in South Africa, a high prevalence and low resource setting.
Methods: The design was a pragmatic cluster-controlled trial with seven intervention and 14 control clinics in
Cape Town. Nurses in intervention clinics integrated PITC into standard HIV care with few additional resources,
whilst lay counselors continued with the VCT approach in control clinics. Routine data were collected for a six-
month period following the intervention in 2007, on new STI patients who were offered and who accepted HIV
testing. The main outcome measure was the proportion of new STI patients tested for HIV, with secondary
outcomes being the proportions who were offered and who declined the HIV test.
Results: A significantly higher proportion of new STI patients in the intervention group tested for HIV as compared
to the control group with (56.4% intervention versus 42.6% control, p = 0.037). This increase was achieved despite
a significantly higher proportion intervention group declining testing when offered (26.7% intervention versus
13.5% control, p = 0.0086). Patients were more likely to be offered HIV testing in intervention clinics, where
providers offered the HIV test to 76.8% of new STI patients versus 50.9% in the control group (p = 0.0029). There
was significantly less variation in the main outcomes across the intervention clinics, suggesting that the
intervention also facilitated more consistent performance.
Conclusions: PITC was successful in three ways: it increased the proportion of new STI patients tested for HIV; it
increased the proportion of new STI patients offered HIV testing; and it delivered more consistent performance
across clinics. Recommendations are made for increasing the impact and feasibility of PITC in high HIV prevalence
and resource-constrained settings. These include more flexible use of clinical and lay staff, and combining PITC
with VCT and other community-based approaches to HIV testing.
Trial registration: Controlled trial ISRCTN93692532
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More than two decades into the AIDS epidemic, the
majority of people living with HIV are unaware of their
status. In 2005, surveys showed that in Sub-Saharan
Africa, the epicentre of the epidemic, only 8% to 25% of
people living with HIV knew their sero-status [1]. Low
testing rates have been linked to a reliance on Voluntary
Counseling and Testing (VCT) as the sole approach to
HIV testing [2]. Barriers to VCT include low perceived
risk for HIV infection, negative perceptions of testing
services, lengthy pre- and post-test counseling and
shortages of counselors [2-5].
Provider-initiated HIV testing and counseling (PITC),
(sometimes referred to as ‘routine offer of testing’ or
‘opt-out testing’) is a streamlined model promoted by
the World Health Organization (WHO) and The Joint
United Nations Program on HIV/AIDS (UNAIDS) to
increase the opportunities for diagnosing HIV in health
facilities, especially in high prevalence countries [6]. In
the PITC approach, all patients are offered HIV testing
routinely by the clinician as part of standard medical
care, regardless of their presenting complaint. Testing
remains voluntary and the patient is given the option to
‘opt-out’ of testing [6]. The aim of PITC is to decrease
barriers to testing in order to increase testing rates and
thereby facilitate earlier access to HIV treatment and
prevention. Early access to treatment has been shown to
reduce morbidity and mortality [7,8]. There is also evi-
dence that knowledge of HIV-positive status can reduce
risk behaviour and transmission rates, especially among
sero-discordant couples [9-11].
Evidence from both low- and high-income countries,
mainly from antenatal and tuberculosis (TB) settings,
indicates that the direct offer of HIV testing by health
providers can result in significant improvements in test
uptake. Effect sizes range from as low as 5% [12] to as
high as 50% [13], while baseline testing rates can vary
from 6% to as high as 75% depending on setting
[2,6,7,14]. There are early indications that PITC may
work in Sub-Saharan Africa, but the evidence is limited
to a few studies among antenatal and TB patients, and
one with patients with sexually transmitted infection
(STI). For example, in Botswana, a significant increase
was reported in antenatal patients who knew their status
(47% to 78%) after introducing PITC [15]. In South
Africa, a cluster randomised trial with newly registered
TB patients showed an increase in testing rates from
6.5% to 20.2% (p = 0.009) [16], and a quasi-experimental
study among hospital outpatients showed an increase in
case detection from an average of eight to 39 HIV cases
per week (p < 0.0001) [17].
Patients with STI, another important high-risk group,
have been less well-studied, particularly in high
prevalence settings, perhaps because of the relative new-
ness of the PITC approach. Given the strong association
between STIs and the risk of acquiring and transmitting
HIV [8,18,19], improving HIV detection and treatment
among STI patients is a pressing issue. Studies in high-
income countries have found high rates of missed
opportunities for HIV testing among STI patients, with
up to 70% of HIV infections remaining unrecognized
[18,20-22], and a study in Malawi indicated that an
alarming number of acute HIV infections are missed in
sexually transmitted disease (STD) clinics [23]. It cannot
be assumed, however, that the PITC success with
antenatal and TB patients will apply to STI patients
because there are other factors that may act as incen-
tives to test among TB and antenatal patients. The
acute, non-recurring nature of STI services also means
there are limited opportunities to offer HIV testing and
thus to increase testing rates. Furthermore, there are
important concerns about the feasibility and ethics of
PITC in resource-constrained settings (many of which
are also high HIV prevalence areas), because it may be
difficult to add PITC effectively to the clinical workload
in under-resourced health services [4,24].
The evidence for PITC with STI patients is limited to
a few quasi-experimental studies in the UK and the
Netherlands [20,21,25,26], and one controlled trial in
Sub-Saharan Africa [27]. The European trials report sig-
nificant increases in HIV testing for STI patients,
although a recent UK study with low-risk STI patients
showed that there was a significant increase in the offer
of testing, not in the proportion of patients who
accepted testing [28]. The one Sub-Saharan African
PITC study with STI patients was a controlled trial in
Botswana that showed a significant increase in HIV test-
ing for STI patients (33% in intervention clinics as com-
pared to 14% in control clinics, p < 0.001) [27].
However, PITC was one of four clinical interventions
that made up the training intervention in this study,
making it difficult to isolate the impact of PITC alone.
No randomised control trials on PITC for STI patients
have been reported.
The close association between HIV and STI, the high
rates of missed opportunities for testing STI patients,
and limited evidence on the effectiveness of PITC for
STI patients in high prevalence and resource-con-
strained settings are of particular concern for high pre-
valence countries like South Africa. In April 2006, the
Cape Town health authorities undertook a trial to evalu-
ate the impact of PITC on the testing rates of STI
patients, compared to the standard VCT approach at
primary care level. In order to evaluate PITC in as rea-
listic a context as possible, the intervention was imple-
mented by existing health managers and with few
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therefore addresses a key gap in evidence regarding the
effectiveness of PITC for STI patients in high prevalence
and resource-constrained settings.
Methods
Study setting
The study was performed in the public sector, primary
healthcare services in Cape Town, South Africa. STI ser-
vices are free of charge and are delivered mostly by
trained nurse practitioners. VCT is the standard
approach and is provided by trained lay health counse-
lors. At the start of the intervention in 2006, the total
new STI caseload for Cape Town was more than 5,000
patients per month, with an estimated 30% HIV testing
rate. Although Cape Town has amongst the lowest HIV
prevalence in the country, the prevalence varies dramati-
cally between sub-districts. In 2005, the average HIV
prevalence for pregnant women was 12.7% [29], whilst
some of the poorest sub-districts had rates of over 30%
which are amongst the highest in the country [30].
The health authority gave permission for the evalua-
tion, and ethical approval was obtained from the Univer-
sity of Cape Town Research Ethics Committee. A
confidentiality agreement was signed between the health
authorities and the research team to ensure additional
protection of patient information.
Study design
The design was a pragmatic cluster non-randomised
controlled trial, in which seven clinics were selected to
receive the intervention, and 14 clinics served as control
clinics. The trial aimed to test the effect of the interven-
tion under normal operational and management condi-
tions. Randomization was not feasible because the
intervention clinics were selected before the evaluation
was planned. The assessment of the intervention was
facilitated by the health management team, which also
made it impractical to blind the implementers and the
assessors.
The primary outcome was the HIV testing rate
amongst new STI clients. Secondary outcomes were the
proportion of STI clients offered HIV testing (irrespec-
tive of whether they accepted or not) and the proportion
that declined HIV testing, once offered. We also
describe the sample in terms of the participant’s gender,
age and proportion diagnosed with HIV.
Study population and sampling
A pool of 24 clinics was identified by the health services
as eligible to participate, based on criteria of geographi-
cal representation (one clinic from each of the health
sub-districts), nurse-patient ratio, and a minimum STI
caseload of 30 new STI patients per month. A project
steering committee, in consultation with local district
managers, selected one representative clinic from each
district. Nine intervention sites were selected initially,
but two clinics declined participation shortly before
implementation, citing operational difficulties. One con-
trol clinic opted out, citing similar reasons. The remain-
ing fourteen eligible clinics became the comparison
group. There was no matching of clinics, but statistical
comparison of clinics at baseline was conducted using
general routine administrative data that were collected
retrospectively.
A sample size validation was done, given that the
intervention arm would consist of seven intervention
clinics. With this restriction, the study would be able to
show an increase of 20% in testing rate from an esti-
mated baseline of 30%, with 80% power, at a 5% signifi-
cance level and using an intra-class correlation
coefficient (ICC) of 0.08 and a cluster size of 90. In a
recent review of ICCs in 188 health systems research
studies, the median ICC used was 0.051 (IQR 0.011 to
0.094). The ICC of 0.08 in this study is closer to the
conservative end of this range [31]. We doubled the
control group to 14 clinics to increase the power of the
study. Based on available data, we assumed a cluster size
of 90 new STI patients per quarter per clinic.
The PITC intervention
This intervention is an adapted version of the ‘ACTS’
approach which includes four brief steps: assess, get
consent, test, and provide supportive services [32]. In
this PITC intervention, the STI nurse offered HIV test-
ing as a standard part of STI care for all STI clients,
and the client had to decline or ‘opt-out’ of this testing.
According to policy in South Africa, written consent
was required (although the WHO guidelines for PITC
allow for only verbal consent). Abbreviated pre-test
counseling consisted of informing patients that HIV is
an STI and recommending that they test for HIV at this
consultation. If they agreed, the nurse would do a brief
test readiness assessment, obtain written informed con-
sent, and perform the rapid test along with other rou-
tine blood tests such as those for syphilis.
By using clinical staff to deliver the intervention as an
integrated part of the STI consultation, the intervention
departed significantly from the standard approach in
South Africa where VCT is predominantly provided by
lay counselors. The shift required a reconfiguration of
roles for nurses and lay counselors, with nurses taking
on some of the tasks previously performed by lay coun-
selors. It was anticipated that more patients would be
tested because the clinical care setting provided the
opportunity to offer HIV testing to all patients, and the
setting may also increase patient willingness to test.
Because this was a demonstration project to evaluate
also the feasibility and acceptability of using clinical staff
for HIV screening (instead of lay workers), the interven-
tion needed to address concerns about the possible
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allowed to refer the patient to the clinic lay counselor
for the test result and post-test counseling once they
completed the STI consult and HIV testing.
STI nurses from each of the intervention sites received
a two-day training course on PITC and how to imple-
ment it. Lay counselors also received training to empha-
size follow-up support for HIV positive clients. The
implementation was standardized in terms of the main
components of integrated nurse-initiated testing, but
clinics were allowed to adapt their patient flow arrange-
ments to suit their clinic. No additional nursing
resources were provided to implement the intervention
at clinic level, but a part-time project manager from
within the health service allocated 30% of her time to
oversee the implementation,s u p e r v i s i o n ,a n dm o n i t o r -
ing of the intervention. Intervention clinics received
quarterly feedback about their performance.
In control sites, the routine VCT approach continued.
The VCT service is available at the same site as the STI
service, and any person can access the VCT service on
his or her own initiative or via medical referral. The
majority of patients using the VCT service would be
required to initiate testing themselves, whilst a few
would be medically referred if they had HIV-related
symptoms or if considered high risk. In addition to
patient barriers to access such as low perceived risk and
poor perception of testing services, the lengthy pre-and
post-test counseling and shortages of counselors are
potential barriers to VCT access in these settings [2-5].
In the VCT service, lay counselors provided pre- and
post-test counseling that lasted an average of 45 minutes
[33]. This excluded waiting time which can be consider-
able in public sector clinics. Due to limits in the scope of
practice of lay workers, a nurse had to perform the rapid
and confirmatory tests, which added to the duration of
VCT and also fragmented the VCT service. In this study,
the pre-test counseling session offered by the lay counse-
lor in the VCT approach and the abbreviated pre-test
counseling offered by the nurse in the PITC intervention
are both captured by the outcome ‘offered HIV testing’.
Data collection and analysis
Data sources and data management
Baseline data for 2005, the year prior to the interven-
tion, were collated for intervention and control clinics
to determine how the two groups compared on clinic
demographics and health service delivery for STI and
HIV testing services. The baseline data summary (Table
1) describes the intervention and control groups accord-
ing to characteristics that may have influence on the
outcomes. Although TB treatment outcomes are not
directly related to STI and HIV service outcomes, it was
included, as this indicator does reflect how well clinics
function in a priority service area.
The intervention was evaluated approximately one
year after the start of implementation, using six months
of routine data from January to June 2007. The routine
monthly report (RMR) collated by the health services
provided data on the numbers of new STI patients. HIV
testing data were collated from the counseling and
Table 1 Baseline comparison of intervention and control clinic demographics and service profile
Caseload Intervention
clinics
(N = 7)
Control
clinics
(N = 14)
P
value
1. Total caseload: annual number of patients treated in 2005 504,679 822,395 0.40
2. Adult caseload: number of patients who were 5 yrs and older 334,758 600,142 0.66
STI services
3. STI-new: number of patients treated who presented with a new episode of STI 8,466 12,377 0.26
4. STI load as a proportion of total adult caseload 3% 2% 0.17
HIV testing services
5. VCT Total: number of patients who received voluntary counseling and testing (VCT) 13,275 19,426 0.33
6. VCT load as a proportion of total adult caseload 4% 2% 0.94
7. Proportion of VCT patients who were female 56% 54% 0.33
8. HIV test acceptance, VCT: proportion of VCT patients who were tested for HIV 93% 85% 0.03*
9. HIV positive rate amongst patients who tested for HIV 29% 28% 0.82
10. Lay Counsellor workload: the average number of VCT patients counseled per lay counsellor per day 4.3 patients 4.7 patients 0.59
TB treatment outcomes
11. VCT for TB: proportion of New Smear Positive TB patients who received VCT 79% 77% 0.63
12. TB success rate: proportion of New Smear Positive TB patients who were successfully treated (combined
TB cure and TB completion rates)
79% 77% 0.97
Annual data for 2005
Data sources for variables numbered: 1 to 4 = Routine Monthly Report (RMR); 5, 7, 8, 9, and 11 = Voluntary Counseling and Testing quarterly reports; 10 =
Quarterly lay counsellor statistics report, 2005; 12 = TB quarterly reports.
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graphics of new STI patients offered HIV testing,
whether they accepted the test, and the HIV test result.
The CT register recorded the type of patients, including
antenatal and TB patients, and was adapted to record
STI patients as a separate category.
Data from the CT register was entered into an Excel
database. Data were linked to patient identifiers, and for
this part of the study we recorded patient record num-
bers, but not patient names. Data quality checks were
done in stages. This involved checking the RMR data,
paper copies of the CT registers, and the electronic data
set for completeness and accuracy. Problems such as
incomplete and inaccurate CT registers (including miss-
ing patient identifiers and missing or inconsistent testing
information) were queried and corrected by clinic staff
through checking patient records. The 10% sample
check at the end identified a particular clinic where
there were anomalies in the data (mainly for gender and
age) and this was corrected. This did not require a
rechecking and re-entry of the whole data set.
Statistical methods
The proportion of patients offered testing, tested, and
declined per clinic was calculated. For the variables
‘HIV tested’, ‘not tested’ and ‘offered HIV testing’ the
denominator was the total number of new STI patients
treated in these clinics. For variable ‘declined HIV test-
ing’ the denominator was the total number of new STI
patients who were offered HIV testing, in other words, a
subgroup of the total new STI population. These pro-
portions were utilized as clinic level outcomes and used
to compare the two groups. This clinic level analysis
accounts for the clustering within clinics [34].
The statistical comparison was done using STATA 10.
A two-sample t-test was used for the comparison of the
study outcome and baseline data between the interven-
tion and control group. We checked the normality
assumption of the t-test. A formal test for the equality
of variances in the two groups was done using the F-
test. The appropriate t-test was subsequently performed
based on the homogeneity status of the variances. Multi-
nomial logistic regression analysis with adjustment for
clustering was done on the composite testing outcome
(’tested’, ‘not tested ‘and ‘not offered’)t oc o n f i r mt h e
results of the clinic level analysis. Only the clinics that
were operationally able to implement the protocol and
provide outcome data to the trial were included in the
analysis because we wanted to know the effectiveness of
the PITC intervention in clinics that actually implemen-
ted the intervention. The statistical adjustment for base-
line differences is not reported and this is considered in
the results and in the study limitations.
Results
The flow chart in Figure 1 provides a profile of the
enrolment, analysis, and results of the trial. It includes
total raw numbers across all clinics along with the
appropriate denominator for each outcome. Note, how-
ever, that the proportions in parentheses are averaged
over the clinics to account for clustering and are thus
not the same as the proportions for the raw numbers
presented.
Baseline comparison
Baseline data on clinic demographics and service deliv-
ery from the start of the intervention in 2005 are pro-
vided in Table 1. There were no significant differences
between the intervention and control groups for either
their STI and HIV testing service delivery characteristics
or their TB treatment outcomes, except for the HIV test
acceptance, VCT variable (p = 0.03).
Proportion tested, offered testing and declined
Clinic level raw data and results are shown in Table 2,
with the proportions for the main outcomes averaged
over clinics. A total of 9,080 new STI patients were trea-
ted during the study period; 3,053 in the intervention and
6,027 in the control group. The main results are shown
in Figure 2 and the corresponding Table 3. The two bars
in Figure 2 represent 100% of the new STI patients seen
in the period of January to June 2007 in both intervention
and control clinics. A significantly greater proportion of
new STI patients were tested for HIV in the intervention
compared to the control group (56.4% intervention ver-
sus 42.6% control, p = 0.037). The increase of 13.8% in
test uptake with the new intervention means that for
every seven new STI patients treated, one additional HIV
test was achieved (NNT = 7.3).
Patients were also more likely to be offered HIV test-
ing in the intervention clinics: intervention clinics
offered the HIV test to 2,326 (76.8%) of new STI
patients compared with 3,406 (50.7%) in the control
group (p = 0.0029). In Figure 2, the proportion of
patients offered testing is made up of a combination of
t h eb l u e( ’HIV tested’)a n dr e d( ’not tested’) sections of
the graph. The ‘not tested’ variable represents the
patients in the CT register who were offered testing but
who declined this. The proportion of patients who
declined testing (’not tested’) in the figure is calculated
as a proportion of all new STI patients.
Another way to measure those who declined testing is
as a proportion of those offered testing. This alternative
calculation represents test refusal within the context of
those offered the test rather than all new STI patients
and is reflected by the variable ‘declined HIV testing’ in
Figure 1, Table 2 and Table 3. Of those patients offered
HIV testing, a significantly greater proportion (26.7%)
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control group (13.5%), p = 0.0086.
As mentioned earlier, the adjusted baseline analysis is
not used. The inverse association observed between the
baseline variable of a broader population and the much
narrower study population may lead to a distorted esti-
mate of the intervention effect. The unadjusted results
reported in the manuscript is a more conservative esti-
mate of the intervention effect when compared to the
adjusted estimate given in this analysis (13.8% compared
to 22.2%). We feel that the unadjusted result is a more
reasonable result with respect to the health system set-
ting in which this was done.
From the multinomial regression (adjusted for cluster-
ing) on the composite testing outcome (tested, not tested,
not offered) the odds ratio for being tested is 2.24 (95% CI:
1.12 to 4.46), p = 0.022 for the intervention group
compared to the control group with the reference category
being ‘not offered’. This result confirms the outcome spe-
cific comparison reported in Figure 2 and Table 3.
Variance in clinic performance
Although not a pre-specified outcome measure, the data
suggested wide variability in range for outcomes mea-
sured in the clinics, and this was compared statistically
using the F test. As shown in Table 3, there was signifi-
cantly less variation in clinic performance in the inter-
vention group for both ‘HIV tested’ (intervention: 39%
to 71%; control: 8% to 81%; p = 0.033) and ‘HIV test
offered’ rates (intervention: 63% to 84% control: 7.8% to
92%; p = 0.0076). Of note is that two control clinics
(clinic number 13 and 21 in Table 2) achieved higher
testing rates than the intervention sites (80.6% and
77.5%, respectively, as compared to the highest rates of
71,1% in the interventions clinics).
Figure 1 Flow chart for PITC controlled trial.
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participants
There were no significant differences in the male to
female ratio between the intervention and control
groups on any of the outcomes examined (Table 4). Of
those who tested, a similar proportion was male (43%)
in both groups. There was no significant difference
between intervention and control clinics in the propor-
tion of patients who tested HIV positive (18,6% in the
intervention and 21,4% in the control group, p = 0.147).
Discussion
A streamlined HIV testing protocol that is integrated
into STI care and delivered by nurses in busy primary
healthcare clinics in Cape Town appears to be effective
and feasible. PITC significantly increased the proportion
of new STI patients who tested for HIV as well as the
proportion of patients offered testing. There was also
significantly less variation in the main outcomes across
the intervention clinics, suggesting that the intervention
facilitated more consistent performance.
The increase in testing rate was achieved even though
only 76% of all STI patients in the intervention clinics
were offered testing. One area for increasing the effec-
tiveness of the PITC intervention is in increasing the
coverage of the offer of testing to 100% of new STI
patients. More than one-quarter of patients offered test-
ing in the intervention group declined to test (twice the
proportion in the control group), a result that is not
favourable to the intervention. The result is understand-
able given that patients did not self-initiate testing, as is
the case for VCT. Nevertheless, reducing the proportion
who decline testing represents another area where the
impact of the PITC intervention could be improved sub-
stantially. This could be done by training staff to use
more effective motivation strategies to encourage
patients to test, provided that this does not compromise
informed consent from patients. The high test refusal
rate found could be considered indirect evidence that
patients were able to exercise their right to decline test-
ing and is therefore an indirect marker of the ethical
implementation of the PITC approach.
Table 2 Comparison of outcomes for the intervention and controls per clinic (’offered HIV testing’, ‘HIV tested’, ‘not
tested for HIV’ and ‘declined HIV testing’).
STI Total Offered HIV testing (%)
(Total offered/Total STI)
HIV tested (%)
(Total tested/Total STI)
Not tested for HIV (%)
(Total declined/Total STI)
Declined HIV testing (%)
(Total declined/Total offered)
Intervention
1 451 363 (80.5) 256 (56.8) 107 (23.7) 107 (29.5)
2 520 400 (76.9) 306 (58.8) 94 (18.1) 94 (23.5)
3 412 346 (84.0) 236 (57.3) 110 (26.7) 110 (31.8)
4 850 572 (67.3) 492 (57.9) 80 (9.4) 80 (14.0)
5 425 338 (79.5) 228 (53.6) 110 (25.9) 110 (32.5)
6 249 215 (86.3) 177 (71.1) 38 (15.3) 38 (17.7)
7 146 92 (63.0) 57 (39.0) 35 (24.0) 35 (38.0)
Total* 3053 2326 (76.8) 1752 (56.4) 574 (20.4) 574 (26.7)
Control
8 421 87 (20.7) 86 (20.4) 1 (0.2) 1 (1.1)
9 174 119 (68.4) 105 (60.3) 14 (8.0) 14 (11.8)
10 388 129 (33.2) 120 (30.9) 9 (2.3) 9 (7.0)
11 166 51 (30.7) 47 (28.3) 4 (2.4%) 4 (7.8)
12 593 197 (33.2) 165 (27.8) 32 (5.4) 32 (16.2)
13 789 669 (84.8) 636 (80.6) 33 (4.2) 33 (4.9)
14 837 684 (81.7) 534 (63.8) 150 (17.9) 150 (21.9)
15 626 333 (53.2) 221 (35.3) 112 (17.9) 112(33.6)
16 320 25 (7.8) 24 (7.5) 1 (0.3) 1 (4.0)
17 373 135 (36.2) 103 (27.6) 32 (8.6) 32 (23.7)
18 164 27 (16.5) 27 (16.5) 0 (0.0) 0 (0)
19 285 211 (74.0) 182 (63.9) 29 (10.2) 29 (13.7)
20 576 449 (78.0) 327 (56.8) 122 (21.2) 122 (27.2)
21 315 290 (92.1) 244 (77.5) 46 (14.6) 46 (15.9)
Total* 6027 3406 (50.7) 2821 (42.7) 585 (8.10) 585 (13.5)
*Note that all the proportions in the ‘Total’ columns are averaged over clinics to account for clustering
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14% is smaller than the difference of 20% anticipated
prior to the study, though it is similar to increases
reported in prior studies in South Africa (13% increase
for TB patients) [16] and Botswana (19% increase for
STI patients) [27]. This study may have underestimated
the impact of the PITC intervention as two practice
shifts could have narrowed the difference between con-
trol and intervention clinic outcomes in the study set-
ting. First, following revisions to the CT register, all
clinics were able to record the testing of new STI
patients. Second, midway through the intervention per-
iod, the health authority set a 50% HIV testing target
for new STI patients across the city. Both of these
changes might have incentivised control clinics to
improve their performance. However, this suggestion
remains speculative due to the lack of baseline testing
rates for STI patients.
The findings have important operational implications
beyond the testing rate itself and relating to the man-
agement of staff resources. In this study, STI nurses
integrated HIV screening into their STI consultations,
taking on a task previously performed by lay health
workers. This is unlike the task shifting recommended
by WHO, where tasks are referred down to less skilled
workers to free up clinical time for treatment and care
of HIV (Type III task shifting) [35,36]. However, it pro-
vides a rational way of utilizing existing staff resources
where there is limited capacity to recruit more lay work-
ers. The change in nursing roles was achieved with rela-
tively short training and by extending slightly their
consultation time (by approximately five to seven
Figure 2 ’HIV tested’, ‘Not tested’ and ‘Not offered’ in intervention and control groups.
Table 3 Proportion of new STI patients who were ‘HIV tested’, ‘offered HIV testing’ and ‘declined HIV testing’ in the
intervention and control groups.
Intervention
N=7
Control
N=1 4
P value
*(p < 0.05)
HIV tested
(% of total STI patients tested for HIV)
56.4% (CI: 49.4-63.2) 42.7% (CI: 31.4-53.8) 0.037*
Clinic range 39 to 71.1% 7.5 to 80.6% 0.033*
Offered HIV testing
(% of total STI patients offered HIV testing)
76.8%
(CI: 68.8 to 84.0)
50.7%
(CI: 34.3 to 72)
0.0029*
Clinic range 63% to 84%% 7.8% to 92.1% 0.0076*
Declined HIV testing**
(% of STI patients offered, but declined testing)
26.7%
(CI:18.70 to 4.7)
13.5%
(CI: 7.6 to 19.4)
0.0086*
Clinic range Range: 14 to 38% Range: 0 to 33% 0.71
**Two-sided t-test since no direction was hypothesized.
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Page 8 of 11minutes on average). Nevertheless, nurses were not able
to implement the intervention in full with all their STI
clients and tended to drop the offer of testing during
busy periods. For nurses to increase the offer of testing
from 76%, as measured in this study, to 100% of new
STI patients, they may require even more streamlined
protocols for the integration of HIV screening into clini-
cal practice.
Where nursing resources are very limited, it may be
less feasible to use only clinical staff for PITC, and lay
providers could be used in such settings [37]. In neigh-
bouring Botswana and Lesotho, the two countries at the
forefront of PITC in Africa, logistical and resource con-
straints to implementing PITC have already emerged,
and there are associated concerns about compromising
patient informed consent [4]. It is possible that such
problems may increase as the intervention is implemen-
ted to scale, and supervision and support are reduced.
Successful scaling up of this PITC intervention in high
prevalence and resource-constrained settings will require
adaptation to the local context, including a flexible
approach to the utilisation of clinical and lay staff.
Retraining of nurses and lay counselors may also be
necessary so as to streamline and integrate HIV testing
more effectively. HIV testing rates could be increased
further through expanding PITC to other categories of
clinic patients; by decreasing the test refusal rate; and
possibly by reducing the requirement for written con-
sent. It is interesting to note that two control clinics
achieved higher testing rates with the VCT approach
than the intervention sites. Further enquiry suggested
that their success was due to the close supervision and
monitoring of the VCT staff team, factors that are also
likely to be important for the successful up-scaling of
PITC.
The findings of this study contributed to the decision
to roll-out a more streamlined version of PITC to sev-
eral sub-districts in Cape Town in 2008. The health
authorities are now formulating policy to scale up the
intervention to the provincial level.
Generalisability
As a pragmatic trial, this intervention was implemented
using existing management and clinical staff resources
and some internal project management support. This
situation, where the service managers initiate and run
the intervention and where there is little additional
resources added, is an ideal context for an effectiveness
evaluation as it reflects the reality of implementation in
resource-constrained settings [38,39]. The estimated
baseline testing rate for STIs of 30% in this study may
be higher than in other low resource settings, and the
staff configurations for HIV service delivery may also
differ. These factors could influence the size of the
impact of the intervention in other settings.
Limitations of the study
The lack of randomization of clinics to intervention and
control groups introduces the risk of bias for the study
outcomes. While the baseline comparison showed few
differences between intervention and control sites, we
cannot exclude other unknown sources of selection bias.
Also, we were not able to obtain baseline measures for
the main outcome. The one baseline testing variable
(HIV test acceptance, VCT) that was significantly differ-
ent across intervention and control sites was inappropri-
ate as a measure of baseline differences for the following
reasons: this variable is not strictly comparable to the
main outcome in this study because it refers to the pro-
portion of general clinic patients who were tested as a
proportion of those who received pre-test counseling by
lay counselors in the VCT service; and it covers a differ-
ent and much larger general patient target group (and
not STI patients only) and refers to a different testing
service (VCT), delivered by lay counselors and not clini-
cians. However, given the lack of baseline data on the
main outcome, we felt that this ‘HIV test acceptance,
VCT’ variable should be examined in the baseline com-
parison of the two groups, and that unadjusted outcome
measures should be presented. In the absence of blind-
ing, factors such as staff enthusiasm and increased mon-
itoring could have had a modifying effect. As mentioned
earlier, we cannot be certain about how the unforeseen
management efforts to increase HIV testing rates, imple-
mented in parallel to this intervention, may have
affected the study results.
Summary
To our knowledge, this is only the second study on the
impact of the PITC approach for STI patients in a high
prevalence African country (the other being in Bots-
wana), and the first where the study design was able to
Table 4 Gender, age, and HIV diagnosis for study participants in the intervention and control groups.
Intervention Control
Proportion tested who were male 42.8% (n = 751) 42.5% (n = 1200)
Proportion offered testing who were male 43.9% (n = 1,012) 43.7% (n = 1490)
Proportion who declined testing who were male 47% (n = 270) 49.6% (n = 290)
Mean age of patients tested for HIV 26 yrs 28 yrs
HIV positive diagnosis for tested patients 18.6% (n = 326) 21.4% (n = 605)
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Page 9 of 11isolate the effect of the PITC intervention. The study
demonstrates that PITC, integrated into STI care and
delivered by nurses in an urban, primary healthcare set-
ting had three successes: it increased the coverage of
HIV testing opportunities, it increased testing uptake,
and it delivered more consistent performance across
clinics.
PITC is recommended as an effective strategy for
increasing the uptake of HIV testing in medical settings
in high prevalence and resource-constrained countries
such as South Africa. However, this study indicates that
this approach alone may not deliver the large-scale
increases in testing required in high prevalence settings.
A multi-faceted strategy to expanding HIV testing and
care may be needed. This should combine PITC with
efforts to optimise existing VCT services. Creative
options for community, home-based, and self testing for
HIV should also be introduced and evaluated. Finally,
efforts to increase testing rates should be matched by
efforts to link newly diagnosed HIV positive patients to
clinical care and prevention services because this is ulti-
mately the aim of HIV testing.
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